PB1841: A NEW APPROACH IN ACUTE MYELOID LEUKEMIA (AML): SAMATYA-PREDICTING SCORE

PB1841: A NEW APPROACH IN ACUTE MYELOID LEUKEMIA (AML): SAMATYA-PREDICTING SCORE

Opis bibliograficzny
Główni autorzy:	I. Serin, B. ORHAN, D. SONMEZ, T. A. CINLI, H. GOZE, H. SERIN, O. YOKUS
Format:	Artykuł
Język:	English
Wydane:	Wiley 2022-06-01
Seria:	HemaSphere
Dostęp online:	http://journals.lww.com/10.1097/01.HS9.0000850216.89828.d5

Podobne zapisy

A new approach in acute myeloid leukemia (AML): Samatya-predicting score
od: Istemi Serin, i wsp.
Wydane: (2022-01-01)

PB1752: SAMATYA-PREDICTING SCORE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): COMBINING CLINICAL FEATURES WITH FLOW CYTOMETRY
od: Tahir Alper Cinli, i wsp.
Wydane: (2023-08-01)

PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL
od: Osman Yokus, i wsp.
Wydane: (2023-08-01)

A Huge Mass in the Liver: Plasmacytoma
od: Tahir Alper Cinli, i wsp.
Wydane: (2022-02-01)

Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience
od: Istemi Serin, i wsp.
Wydane: (2022-11-01)

PB1896: ACUTE MYELOID LEUKEMIA (AML): REAL-WORLD DATA FROM LEBANON
od: Lewis Nasr, i wsp.
Wydane: (2023-08-01)

AngioCRIME in Acute Myeloid Leukemia (AML)
od: Elizabeth Macintyre, i wsp.
Wydane: (2017-12-01)

Secondary Immunodeficiency Frequency in Patients with Chronic Lymphocytic Leukemia: The Relationship with Stage and Treatment
od: Osman Yokus, i wsp.
Wydane: (2022-01-01)

PB1812: CO-MUTATION PROFILE IN A REAL-LIFE COHORT OF ACUTE MYELOID LEUKEMIA (AML)
od: Giovanna Piras, i wsp.
Wydane: (2023-08-01)

Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
od: Omer Jamy, i wsp.
Wydane: (2024-10-01)

PB1841: NUCLEOLIN INTERACTS WITH NUCLEOPHOSMIN AS A PREDICTOR OF PROGNOSIS IN ACUTE MYELOBLASTIC LEUKEMIA
od: Marta Pereira, i wsp.
Wydane: (2023-08-01)

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy
od: Thomas Büchner, i wsp.
Wydane: (2004-07-01)

Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo¬therapy
od: Thomas Büchner, i wsp.
Wydane: (2004-07-01)

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy
od: Thomas Büchner, i wsp.
Wydane: (2004-03-01)

Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo-therapy
od: Thomas Büchner, i wsp.
Wydane: (2004-03-01)

Acute Myeloid Leukemia (AML) as a model for cancer therapy
od: Farhad eRavandi
Wydane: (2012-10-01)

Prognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
od: Weijie Cao, i wsp.
Wydane: (2022-11-01)

PB2075: HOW EFFECTIVE ARE LEPTIN GENE POLYMORPHISMS AND METHYLATION DURING THE COURSE OF MULTIPLE MYELOMA (MM)?
od: Istemi Serin, i wsp.
Wydane: (2023-08-01)

Acute Myeloid Leukemia (AML) Detection Using AlexNet Model
od: Maneela Shaheen, i wsp.
Wydane: (2021-01-01)

Treatment of acute myeloid leukemia (AML): Recent results and new directions
od: Thomas Büchner University of Münster, i wsp.
Wydane: (2004-08-01)

Treatment of acute myeloid leukemia (AML): Recent results and new directions
od: Thomas Büchner
Wydane: (2004-03-01)

Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
od: Fabio Guolo, i wsp.
Wydane: (2022-09-01)

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
od: Jing Chen, i wsp.
Wydane: (2020-02-01)

Targeting the innate immune system as immunotherapy for Acute Myeloid Leukemia (AML)
od: Emily Kathleen Curran, i wsp.
Wydane: (2015-04-01)

A case with acute myeloid leukemia and hepatosplenic Candida parapsilosis
od: Habip Gedik, i wsp.
Wydane: (2015-01-01)

PB1831: UTILITY OF FLT3 INHIBITORS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND T(6;9)(P22;Q34)
od: F. Ong, i wsp.
Wydane: (2022-06-01)

PB2234: EFFECT OF HYDROXYUREA ON INFLAMMATORY MARKERS IN PATIENTS WITH BCR-ABL NEGATIVE MYELOPROLIFERATIVE DISEASES
od: Oguz Altunok, i wsp.
Wydane: (2023-08-01)

PB1788: A SCREENING OF DONATED CHEMICAL PROBES TO IDENTIFY NOVEL THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA (AML) IN CHILDHOOD
od: Stephanie Laszig, i wsp.
Wydane: (2023-08-01)

Conventional Cytogenetic and Molecular Analysis in Acute Myeloid Leukemia (AML) and Their Association with Overall Survival
od: Shakeri S., i wsp.
Wydane: (2021-11-01)

Acute Myeloid Leukemia (AML) With T-Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML)
od: Anthony Crymes, i wsp.
Wydane: (2024-01-01)

PB1852: COMPARISON OF CLINICAL CHARACTERISTICS OF ADULT CHILEAN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML), ACCORDING TO THEIR HEALTH CARE SYSTEM: ANALYSIS WITHIN THE FRAMEWORK OF THE PTHEMA AML REGISTRY
od: Monica Romero, i wsp.
Wydane: (2023-08-01)

P478: MOLECULAR CHARACTERIZATION OF EXTRAMEDULLARY LOCALIZATIONS IN ACUTE MYELOID LEUKEMIA (AML)
od: Giorgia Silvestrini, i wsp.
Wydane: (2023-08-01)

Treatment of acute myeloid leukemia (AML): Recent results and new directions1
od: Thomas Büchner University of Münster, i wsp.
Wydane: (2005-06-01)

Treatment of acute myeloid leukemia (AML): Recent results and new directions1
od: Thomas Büchner
Wydane: (2005-03-01)

The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (AML)?
od: Atousa Haghi, i wsp.
Wydane: (2022-10-01)

Effective Dendritic Cell-based Immunotherapeutic Vaccines for Acute Myeloid Leukemia (AML)
od: Maryam Nourizadeh, i wsp.
Wydane: (2014-11-01)

A Rare Cytogenetic Presentation of Acute Myeloid Leukemia (AML-M2)
od: Prasanna Kumari, i wsp.
Wydane: (2012-12-01)

A Rare Cytogenetic Presentation of Acute Myeloid Leukemia (AML-M2)
od: Hanumanthappa Vijay Raghavendra, i wsp.
Wydane: (2012-12-01)

Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches
od: Eric S. Winer, i wsp.
Wydane: (2019-07-01)

PB1790: LOOKING ‘BENEATH’ THE SURFACE: PROTEOMICS AND GLYCIPROTEOMICS REVEAL NOVEL TARGETS FOR CAR-T CELL THERAPIES IN ACUTE MYELOID LEUKEMIA (AML)
od: Josephine Brysting, i wsp.
Wydane: (2023-08-01)